(Q54072863)

24 May 2018

title

In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri. (English)

1 reference

24 May 2018

main subject

antibiotic

0 references

Streptococcus pneumoniae

1 reference

1 reference

Kays MB

1

1 reference

24 May 2018

Wood KK

series ordinal

2

1 reference

24 May 2018

Miles DO

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

24 May 2018

published in

Pharmacotherapy

1 reference

24 May 2018

volume

19

1 reference

24 May 2018

issue

11

1 reference

24 May 2018

page(s)

1308-1314

1 reference

24 May 2018

Antimicrobial Resistance in Streptococcus pneumoniae: An Overview

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Antimicrobial resistance issues of the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics of cefprozil in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Penetration of cefprozil into middle ear fluid of patients with otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics and bactericidal activity of cefuroxime axetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics of cefuroxime axetil suspension in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Cefpodoxime pharmacokinetics in children: effect of food

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics of cefaclor in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics of LY163892 in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetic profile of loracarbef

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Clinical implications of antibiotic resistance for management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Penicillin-resistant pneumococci in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Clinical pharmacokinetics of amoxicillin and clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Absorption of valproic acid from the gastrointestinal tract of the piglet

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Implications of drug-resistant Streptococcus pneumoniae for otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Penicillin-resistant Streptococcus pneumoniae in acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

Antibiotic-resistant Streptococcus pneumoniae in acute otitis media: overview and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.16.1308.30869

10.1592/PHCO.19.16.1308.30869

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018